- Home
- IMMP vs CRNT Comparison
IMMP vs CRNT Comparison
Compare IMMP & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- CRNT
- Stock Information
- Founded
- IMMP 1987
- CRNT 1996
- Country
- IMMP Australia
- CRNT Israel
- Employees
- IMMP N/A
- CRNT N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- CRNT Radio And Television Broadcasting And Communications Equipment
- Sector
- IMMP Health Care
- CRNT Technology
- Exchange
- IMMP Nasdaq
- CRNT Nasdaq
- Market Cap
- IMMP 211.1M
- CRNT 186.7M
- IPO Year
- IMMP N/A
- CRNT 2000
- Fundamental
- Price
- IMMP $1.78
- CRNT $2.37
- Analyst Decision
- IMMP Buy
- CRNT Strong Buy
- Analyst Count
- IMMP 1
- CRNT 5
- Target Price
- IMMP $7.00
- CRNT $5.85
- AVG Volume (30 Days)
- IMMP 150.7K
- CRNT 614.1K
- Earning Date
- IMMP 02-27-2025
- CRNT 05-07-2025
- Dividend Yield
- IMMP N/A
- CRNT N/A
- EPS Growth
- IMMP N/A
- CRNT 367.84
- EPS
- IMMP N/A
- CRNT 0.25
- Revenue
- IMMP $3,019,249.00
- CRNT $394,344,000.00
- Revenue This Year
- IMMP $50.37
- CRNT $3.12
- Revenue Next Year
- IMMP N/A
- CRNT $7.89
- P/E Ratio
- IMMP N/A
- CRNT $9.55
- Revenue Growth
- IMMP 24.11
- CRNT 11.94
- 52 Week Low
- IMMP $1.32
- CRNT $1.95
- 52 Week High
- IMMP $2.86
- CRNT $5.73
- Technical
- Relative Strength Index (RSI)
- IMMP 44.44
- CRNT 52.35
- Support Level
- IMMP $1.88
- CRNT $2.23
- Resistance Level
- IMMP $1.94
- CRNT $2.46
- Average True Range (ATR)
- IMMP 0.12
- CRNT 0.08
- MACD
- IMMP -0.03
- CRNT 0.01
- Stochastic Oscillator
- IMMP 0.00
- CRNT 60.87
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.